Inactive Instrument

NuVasive, Inc.

Equities

NUVA

US6707041058

Medical Equipment, Supplies & Distribution

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Globus Medical Launches Precice Bone Transport in Select Markets MT
NuVasive, Inc.(NasdaqGS:NUVA) dropped from NASDAQ Composite Index CI
Globus Medical Completes Merger With NuVasive MT
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 600 Health Care CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 600 CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Healthcare Equipment Select Industry Index CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Composite 1500 CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P TMI Index CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P 1000 CI
NuVasive, Inc.(NasdaqGS:NUVA) dropped from S&P Global BMI Index CI
Globus Medical, Inc. completed the acquisition of NuVasive, Inc. from BlackRock, Inc., The Vanguard Group, Inc., Thrivent Financial for Lutherans and others for $2.6 billion. CI
Goosehead Insurance, Jackson Financial Advance Amid Addition to S&P SmallCap 600 MT
Goosehead Insurance, Jackson Financial to be Added to S&P SmallCap 600 MT
Barclays Adjusts Price Target on NuVasive to $58 From $56, Maintains Overweight Rating MT
Transcript : NuVasive, Inc., Q2 2023 Earnings Call, Aug 02, 2023
Earnings Flash (NUVA) NUVASIVE Reports Q2 Revenue $317.8M, vs. Street Est of $323.1M MT
Earnings Flash (NUVA) NUVASIVE Reports Q2 EPS $0.56, vs. Street Est of $0.55 MT
NuVasive, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NuVasive, Inc. Provides Sales Guidance for the Full Year 2023 CI
Truist Securities Adjusts Price Target on NuVasive to $51 From $48, Maintains Hold Rating MT
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell Small Cap Comp Value Index CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 2000 Value-Defensive Index CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 3000E Value Index CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 2500 Value Index CI
NuVasive, Inc.(NasdaqGS:NUVA) added to Russell 2000 Value Index CI
Chart NuVasive, Inc.
More charts
NuVasive, Inc. is a medical technology company. The Company is focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. It offers a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for the spine and specialized orthopedic procedures. It also designs and sell expandable growing rod implant systems for the treatment of early-onset scoliosis that can be non-invasively lengthened after implantation with incremental adjustments via an external remote controller using magnetic technology called MAGneticExternal Control (MAGEC). It operates in more than 50 countries serving surgeons, hospitals, and patients.
More about the company
  1. Stock
  2. Equities
  3. Stock NuVasive, Inc. - Nasdaq
  4. News NuVasive, Inc.
  5. Morgan Stanley Adjusts NuVasive's Price Target to $62 From $67, Maintains Equalweight Rating